Niki BioSolutions, Inc. Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
Niki BioSolutions, Inc. (NIKI) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 1.29 million shares for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-30.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2024-04-30
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 6 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 12 month |
|---|---|---|
| 2023-12-31 | 1.29M shares 20-F · filed 2024-04-30 | |
| 2023-06-30 | 775.34K shares 6-K · filed 2023-12-22 | |
| 2022-12-31 | 54.05K shares 20-F · filed 2024-04-30 | |
| 2022-06-30 | 621.10K shares 6-K · filed 2023-12-22 | |
| 2021-12-31 | 54.05K shares 20-F · filed 2024-04-30 |